Sandesh Mahatme
2018
In 2018, Sandesh Mahatme earned a total compensation of $4.2M as Executive Vice President, Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $335,943 |
|---|---|
| Option Awards | $3,360,191 |
| Salary | $498,112 |
| Other | $24,838 |
| Total | $4,219,084 |
Mahatme received $3.4M in option awards, accounting for 80% of the total pay in 2018.
Mahatme also received $335.9K in non-equity incentive plan, $498.1K in salary and $24.8K in other compensation.
Rankings
In 2018, Sandesh Mahatme's compensation ranked 2,597th out of 14,244 executives tracked by ExecPay. In other words, Mahatme earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,597 out of 14,244 | 82nd |
Division Manufacturing | 955 out of 5,762 | 83rd |
Major group Chemicals And Allied Products | 325 out of 2,125 | 85th |
Industry group Drugs | 264 out of 1,814 | 85th |
Industry Pharmaceutical Preparations | 206 out of 1,388 | 85th |
Pay ratio
| Sandesh Mahatme's Pay | $4,219,084 |
|---|---|
| Median Employee's Pay | $329,229 |
| Pay Ratio | 13to 1 |
In 2018, the annual total compensation of Sandesh Mahatme was $4,219,084.
The annual total compensation of the median employee at Sarepta Therapeutics was $329,229.
The ratio of Sandesh Mahatme's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 26, 2019.
Mahatme's colleagues
We found four more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2018.